Objective Imaging represents an important noninvasive means to assess cystic fibrosis (CF)
lung disease, which remains the main cause of morbidity and mortality in CF patients. While …

To assess airway and lung parenchymal damage non-invasively in cystic fibrosis (CF), chest
MRI has been historically out of the scope of routine clinical imaging due to technical …

Purpose To evaluate detection and characterization of groundglass and fibrosis-like
opacities imaged by non-contrast 0.55 Tesla MRI, and versus clinically-acquired chest CT …

With an increasing number of patients with cystic fibrosis (CF) receiving highly effective
CFTR (cystic fibrosis transmembrane regulator protein) modulator therapy, particularly at a …

The recent introduction of triple-combination CF transmembrane regulator therapy has put
further emphasis on the need for sensitive methods of monitoring treatment response to …

Background Allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) patients
is associated with severe lung damage and requires specific therapeutic management …

Respiratory tract exacerbations play a crucial role in progressive lung damage of people
with cystic fibrosis, representing a major determinant in the loss of functional lung tissue …

Imaging plays an important role in the various forms of Aspergillus-related pulmonary
disease. Depending on the immune status of the patient, three forms are described with …

Cystic fibrosis (CF) is one of the most common inherited and life-shortening pulmonary
diseases in the Caucasian population. With the widespread introduction of newborn …

Background Imaging has played a pivotal role in the diagnosis of idiopathic pulmonary
fibrosis (IPF). Recent reports suggest that T2‐weighted MRI could be sensitive to monitor …